Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
CTI Biopharma
CTI Biopharma
(CTIC)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Vonjo
Pacritinib
2022-02-28
2028-2030
Primary myelofibrosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pacritinib
healthy volunteers/patients
,
drug interactions
,
myelomonocytic leukemia acute
,
leukemia myeloid chronic atypical bcr-abl negative
,
syndrome
,
non-small-cell lung carcinoma
,
lung neoplasms
,
renal insufficiency
,
t-cell lymphoma peripheral
,
t-cell lymphoma cutaneous
,
b-cell lymphoma
,
liver diseases
,
hepatic insufficiency
,
myelodysplastic syndromes
,
myeloproliferative disorders
,
leukemia
,
myelomonocytic leukemia chronic
,
myeloid leukemia acute
,
neoplasms
,
lymphoma
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
preleukemia
,
lymphoproliferative disorders
,
mantle-cell lymphoma
,
bcr-abl positive chronic myelogenous leukemia
,
lymphoid leukemia
,
graft vs host disease
,
b-cell chronic lymphocytic leukemia
,
t-cell lymphoma
,
prostatic neoplasms
,
waldenstrom macroglobulinemia
,
hodgkin disease
,
monocytic leukemia acute
,
myelodysplastic-myeloproliferative diseases
,
recurrence
,
precursor cell lymphoblastic leukemia-lymphoma
,
breast neoplasms
,
hereditary sensory and autonomic neuropathies
,
covid-19
,
colorectal neoplasms
,
fibrosis
,
inflammation
,
aplastic anemia
,
refractory anemia with excess of blasts
,
adenocarcinoma of lung
,
hematologic neoplasms
,
b-cell lymphoma marginal zone
,
primary myelofibrosis
,
polycythemia vera
,
essential thrombocythemia
,
thrombocytosis
,
polycythemia
,
bone marrow diseases
,
thrombocytopenia
,
hematologic diseases
,
anemia
,
blood platelet disorders
,
hemorrhagic disorders
,
splenomegaly
TOSEDOSTAT
neoplasms
,
healthy volunteers/patients
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
neoplasm metastasis
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
multiple myeloma
,
plasma cell neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use